Heterogeneity of monoclonal antibodies
- PMID: 17828757
- DOI: 10.1002/jps.21180
Heterogeneity of monoclonal antibodies
Abstract
Heterogeneity of monoclonal antibodies is common due to the various modifications introduced over the lifespan of the molecules from the point of synthesis to the point of complete clearance from the subjects. The vast number of modifications presents great challenge to the thorough characterization of the molecules. This article reviews the current knowledge of enzymatic and nonenzymatic modifications of monoclonal antibodies including the common ones such as incomplete disulfide bond formation, glycosylation, N-terminal pyroglutamine cyclization, C-terminal lysine processing, deamidation, isomerization, and oxidation, and less common ones such as modification of the N-terminal amino acids by maleuric acid and amidation of the C-terminal amino acid. In addition, noncovalent associations with other molecules, conformational diversity and aggregation of monoclonal antibodies are also discussed. Through a complete understanding of the heterogeneity of monoclonal antibodies, strategies can be employed to better identify the potential modifications and thoroughly characterize the molecules.
Similar articles
-
Method to convert N-terminal glutamine to pyroglutamate for characterization of recombinant monoclonal antibodies.Anal Biochem. 2013 May 1;436(1):10-2. doi: 10.1016/j.ab.2013.01.017. Epub 2013 Jan 25. Anal Biochem. 2013. PMID: 23357233
-
Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development.J Pharm Biomed Anal. 2006 Oct 11;42(4):455-63. doi: 10.1016/j.jpba.2006.05.008. Epub 2006 Jul 7. J Pharm Biomed Anal. 2006. PMID: 16828250
-
Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.Anal Chem. 2016 Feb 16;88(4):2041-50. doi: 10.1021/acs.analchem.5b02800. Epub 2016 Jan 29. Anal Chem. 2016. PMID: 26824491
-
In vitro and in vivo modifications of recombinant and human IgG antibodies.MAbs. 2014;6(5):1145-54. doi: 10.4161/mabs.29883. Epub 2014 Oct 30. MAbs. 2014. PMID: 25517300 Free PMC article. Review.
-
Modifications of recombinant monoclonal antibodies in vivo.Biologicals. 2019 May;59:1-5. doi: 10.1016/j.biologicals.2019.03.006. Epub 2019 Mar 23. Biologicals. 2019. PMID: 30910309 Review.
Cited by
-
Investigation of monoclonal antibody dimers in a final formulated drug by separation techniques coupled to native mass spectrometry.MAbs. 2020 Jan-Dec;12(1):e1781743. doi: 10.1080/19420862.2020.1781743. MAbs. 2020. PMID: 32633190 Free PMC article.
-
Assessing monoclonal antibody product quality attribute criticality through clinical studies.MAbs. 2010 Sep-Oct;2(5):500-7. doi: 10.4161/mabs.2.5.12897. Epub 2010 Sep 1. MAbs. 2010. PMID: 20671426 Free PMC article. Review.
-
Expression vector-derived heterogeneity in a therapeutic IgG4 monoclonal antibody.MAbs. 2019 Jan;11(1):145-152. doi: 10.1080/19420862.2018.1540254. Epub 2018 Nov 7. MAbs. 2019. PMID: 30365358 Free PMC article.
-
Complementary middle-down and intact monoclonal antibody proteoform characterization by capillary zone electrophoresis - mass spectrometry.Electrophoresis. 2018 Aug;39(16):2069-2082. doi: 10.1002/elps.201800067. Epub 2018 Jun 5. Electrophoresis. 2018. PMID: 29749064 Free PMC article.
-
Capillary Electrophoresis Separation of Monoclonal Antibody Isoforms Using a Neutral Capillary.J Vis Exp. 2017 Jan 16;(119):55082. doi: 10.3791/55082. J Vis Exp. 2017. PMID: 28117815 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources